The Effect of Thumb Spica Splint in Management of De Quervain's Disease

Abstract

Background: De Quervain's disease is characterized bypain in the wrist and hand, and it is brought on by theentrapment of the tendons of the extensor pollicis brevisand abductor pollicis longus in the first dorsalcompartment of the wrist. Immobilization, heat and coldtherapy, an electrical nerve stimulator, a thumb stabilizersplint, posture correction, and tool and equipmentadjustments are all examples of non-pharmaceuticaltreatments. Objective: To see the impact of Spica SplintTreatment on De Quervain's Disease Management.Materials and Methods: A clinical trial with 60 adultpatients diagnosed with De Quervain's disease wasconducted for six months at DMCH's Physical Medicineand Rehabilitation outpatient department. Both groupswere told to follow ADL instructions for the affected hand.Results were assessed using VAS and PRWE scales. Patients were evaluated weekly for 6weeks. Significance levels were evaluated using paired t-tests and chi-square tests as needed.Results: argest age range was 41–45 (36.67%), followed by 46–50 (33.33%), with a meanage of 41.775.43 years. More women than men by a factor of 1: 7.6. 53% had the disease in their right hand, 42% in their left, and 5% in both. Both groups had similar VAS and PRWEscores before treatment. The two patient groups had noteworthy mean changes in all threefollow-ups (p=<0.001). Thumb splint helped 36.67% of patients with pain. Conclusion: Athumb spica splint, combined with standard treatments, reduces morbidity and relieves painin de Quervain's tenosynovitis patients, as per study.